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Diderot, Paris 7, Clichy, FranceSee Article, pages 462–470Compared to time spent on the waiting list which was the main
criteria for the allocation of liver allografts a decade ago or less,
the MELD score is generally considered a guarantee of transpar-
ency, objectivity and equity. Since allografts from deceased
donors are a scarce resource, an equitable allocation policy is
an absolute prerequisite in liver transplantation. The MELD score
is a robust marker of early mortality in cirrhotic patients [1]. This
score relies on 3 objective and readily available variables (biliru-
bin, INR and creatinine) that can be easily updated according to
disease progression. Prioritization of patients with the highest
MELD score, those who are at higher risk of death without trans-
plantation, was associated with fewer candidates to be added to
the waiting list and a decrease in waiting list mortality. Impor-
tantly, transplanting the sickest patients did not result in a signif-
icant deterioration of post-transplant survival [2]. The MELD
score-based allocation policy has been widely adopted in most
Western countries.
Even though the MELD score is considered a model of robust-
ness and objectivity, intrinsic limitations have been pointed out.
Renal function has a determinant prognostic value in cirrhosis
[3]. However, serum creatinine, as a marker of renal function, is
a source of inaccuracies and misclassiﬁcations. There are several
pitfalls in the interpretation of serum creatinine including signif-
icant variations over time (especially in patients receiving diuret-
ics) and inter-laboratory variations (especially in patients with
jaundice, due to laboratory interactions with bilirubin). Patients
with decreased muscle mass, a common ﬁnding in cirrhosis,
may have falsely low serum creatinine. For the calculation of
the MELD score, creatinine values below 1 mg/dl are bounded
to 1 mg/dl to avoid negative values after logarithmic transforma-
tion. Bounding creatinine to 1 mg/dl is questionable since cir-
rhotic patients with low creatinine may have markedly
impaired renal function [4]. Finally, it was suggested that creati-
nine might weigh too heavily in the MELD score [5]. Creatinine-Journal of Hepatology 20
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eral, equations tend to overestimate glomerular ﬁltration rate
(GFR). Two recent studies have shown that a score incorporating
true GFR rather than creatinine or creatinine-based equations
would be more accurate than the existing MELD score [4,6].
Unfortunately, direct measurement is technically complex and
poorly suited to be repeated at short intervals.
In 2008, a large survey aimed at comparing pre- and post-
MELD eras in the United States had shown that, while following
the introduction of MELD, race disparities were no longer
observed, gender disparities were still present; women being less
likely to be transplanted than men [2]. It was speculated that the
difference could result from lower muscle mass in women, lower
creatinine value for a given GFR and, as a consequence, a lower
MELD score. Indeed, others had shown that women with cirrhosis
have lower GFR for the same creatinine value, the difference rep-
resenting a systematic disadvantage for women [7].
In this issue of the Journal of Hepatology, based on a very large
series of candidates for transplantation registered in the United
States, Myers et al. conﬁrm that under the MELD era, women
were still disadvantaged compared to men [8]. By chance, differ-
ences between women and men were numerically small in terms
of waiting list mortality (11.3% versus 10.5% waiting list mortality
within 3 months of listing). However, differences were highly sig-
niﬁcant, probably due to the large size of the study population.
Disadvantage predominated in women with a high MELD score
(between 21 and 35) while no difference was observed for a score
below 21. The results strongly suggest that women disadvantage
was due to an overestimation of renal function by creatinine.
Indeed, women had signiﬁcantly lower serum creatinine than
men while the two other components of the MELD score, biliru-
bin and INR, were similar in both groups (except for some MELD
strata). An important ﬁnding is that in the whole population, the
median value of serum creatinine at registration was 1 mg/dl.
Therefore, for the calculation of the MELD score, creatinine had
to be arbitrarily bound to 1 mg/dl in about 50% of candidates
for transplantation. This represents a clear limitation of the MELD
score as the assumption that mortality risk relative to renal func-
tion would be homogeneous in all patients with serum creatinine
less than 1 mg/dl is likely to be wrong. Nevertheless, the propor-
tion of patients in whom creatinine was bound to 1 mg/dl was11 vol. 54 j 401–402
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higher in women (52%) than in men (42%, p<0.05). The authors
found that a score including GFR estimated by the modiﬁcation
of diet in renal disease (MDRD) equation (eGFR) was not superior
to the existing MELD score in terms of discrimination and calibra-
tion, even when serum Na was included. Therefore, using eGFR
instead of creatinine would not overcome the disadvantage in
women. This ﬁnding is not really surprising since eGFR is based
on creatinine, and creatinine is an inaccurate marker of renal
function in cirrhosis. In theory, taking into account MDRD could
help lessen the difference between men and women because
the weight given to creatinine in the equation differs according
to gender. Taken together, these results clearly show that the
weight given to creatinine according to gender in the MDRD
equation is not valid in cirrhosis. Unfortunately, this study does
not address the issue of whether using true GFR instead of creat-
inine could make the access to transplantation comparable in
men and women. In addition, even if the ﬁndings strongly sug-
gest that creatinine was the main cause of disparity between
men and women, other factors independent of renal function
could play a signiﬁcant role. Experience shows that small size
in women frequently results in more difﬁcult matching between
the donor and the recipient. Nevertheless, the present study ele-
gantly highlights that the existing MELD score may be a source of
unexpected disparities, that it is not a universal guarantee of
equity and that improved accuracy is needed, since equity is a
central in liver transplantation. Direct measurement of GFR is
the gold standard. However, since it is not suited for routine
use, indirect markers and/or equations that accurately assess
renal function in patients with cirrhosis are needed to improve
prognostic scores.
This study by Myers et al. is based on the United Network for
Organ Sharing (UNOS) database, from the United States [8]. Using
the UNOS database offers a number of advantages with a very
large number of patients coming from different centers. Large
cohorts provide high statistical power and accurate adjustments.
The database is systematically implemented with new registrants
and outcomes are updated. However, the UNOS database also has
a number of limitations. The population is limited to the United
States and some data (such as ethnicity and distance between
donor and recipient) are not necessarily relevant outside the Uni-
ted States. This database has not been designed for the purpose of
research alone [9]. Recently, concerns have been raised about
inaccuracies and missing data [2]. Importantly, event though
the number of patients entered in the database is very large,
the number of variables to be analyzed is relatively limited.
Again, the purpose is not research. A database, even smaller in
terms of population, including more original markers of renal
function such as cystatin C and/or measured GFR could help
better understand the mechanisms of discrepancies between
men and women. The use of the UNOS/OPTN database can
be seen as a too easy option for addressing certain issues. It
clearly appears that there has been a trend for overexploitation
of UNOS/OPTN database-derived studies with more than
130 original studies corresponding to the key words ‘‘liver402 Journal of Hepatology 201transplantation’’ and ‘‘UNOS and/or OPTN’’ published between
2000 and 2010 according to the PubMed online library [10];
overexploitation with a limited number of variables to analyze
necessary results in redundant publications. Efforts should be
made to consider original approaches, even if coming from
smaller series, in order to improve knowledge. Efforts should
also be made by European and Asian societies to implement
multicenter databases and analyze the results.
The concept of a ‘‘sickest ﬁrst’’ allocation policy, based on the
MELD score, has been a major step forward in liver transplanta-
tion. Despite objective limitations and many criticisms, the MELD
score which gives priority to the sickest patients should not be
abandoned. As it is a robust prognostic tool throughout a wide
spectrum of liver diseases, further improvement in prognostica-
tion will be very difﬁcult to achieve. However, equity in liver allo-
cation will remain central in future years and any improvement,
even if modest, is a necessary goal. Improving equity possibly
means switching from a very simple allocation policy to a much
more complex system taking into account speciﬁc conditions and
including more subtle adjustments.
The bad news is that women are less likely to be transplanted
than men when they are listed for transplantation. But the good
news is that for a number of reasons, women are less likely than
men to develop end-stage liver disease and/or hepatocellular car-
cinoma with the need to be listed for transplantation.
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